| 000 | 01874 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250513195833.0 | ||
| 264 | 0 | _c20000106 | |
| 008 | 200001s 0 0 eng d | ||
| 022 | _a0020-7136 | ||
| 024 | 7 |
_a10.1002/(sici)1097-0215(20000101)85:1<87::aid-ijc16>3.0.co;2-k _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDurrant, L G | |
| 245 | 0 | 0 |
_a105Ad7 cancer vaccine stimulates anti-tumour helper and cytotoxic T-cell responses in colorectal cancer patients but repeated immunisations are required to maintain these responses. _h[electronic resource] |
| 260 |
_bInternational journal of cancer _cJan 2000 |
||
| 300 |
_a87-92 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntibodies, Anti-Idiotypic _xadministration & dosage |
| 650 | 0 | 4 |
_aCD4-Positive T-Lymphocytes _ximmunology |
| 650 | 0 | 4 |
_aCD55 Antigens _ximmunology |
| 650 | 0 | 4 |
_aCD8-Positive T-Lymphocytes _ximmunology |
| 650 | 0 | 4 |
_aCancer Vaccines _xadministration & dosage |
| 650 | 0 | 4 |
_aColorectal Neoplasms _ximmunology |
| 650 | 0 | 4 | _aDose-Response Relationship, Immunologic |
| 650 | 0 | 4 |
_aEpitopes, T-Lymphocyte _ximmunology |
| 650 | 0 | 4 |
_aHLA-DR Antigens _ximmunology |
| 650 | 0 | 4 | _aHistocompatibility Testing |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunization, Secondary |
| 650 | 0 | 4 |
_aImmunologic Memory _xdrug effects |
| 650 | 0 | 4 | _aImmunophenotyping |
| 650 | 0 | 4 |
_aLeukocyte Common Antigens _xbiosynthesis |
| 650 | 0 | 4 |
_aT-Lymphocytes, Cytotoxic _ximmunology |
| 650 | 0 | 4 |
_aT-Lymphocytes, Helper-Inducer _ximmunology |
| 700 | 1 | _aBuckley, D J | |
| 700 | 1 | _aRobins, R A | |
| 700 | 1 | _aSpendlove, I | |
| 773 | 0 |
_tInternational journal of cancer _gvol. 85 _gno. 1 _gp. 87-92 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/(sici)1097-0215(20000101)85:1<87::aid-ijc16>3.0.co;2-k _zAvailable from publisher's website |
| 999 |
_c10541767 _d10541767 |
||